Business Context and Reporting Period
Company: 60 Degrees Pharmaceuticals, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 12, 2026
Reporting Period: Single event date (March 12, 2026)
Business Context: The Company is an emerging growth company incorporated in Delaware. It maintains an "at-the-market" (ATM) equity offering program pursuant to a Sales Agreement dated September 5, 2025, with HC Wainwright & Co., LLC.
Key Financial Metrics
This filing is a current report regarding a legal opinion and does not contain financial statements. Consequently, the filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
There are no material changes to financial performance or operational metrics reported in this document. The sole material event is the filing of an updated legal opinion of counsel regarding the shares of common stock issued and sold under the ATM Program.
Guidance, Outlook, and Management Commentary
- Event Description: On March 12, 2026, the Company filed an updated legal opinion from Sichenzia Ross Ference Carmel LLP.
- Purpose: The opinion provides confirmation regarding the validity of shares that may be sold under the ATM Program and addresses certain matters related to the offering under applicable law.
- Impact on Terms: The updated legal opinion does not affect the existing terms of the ATM Program.
- Risks and Contingencies: No new risks or contingencies were disclosed in this specific filing beyond the standard qualification that the description of the opinion is not complete and is qualified by reference to the full text of Exhibit 5.1.
Investor Verification Checklist
- Verify the full text of the updated legal opinion filed as Exhibit 5.1 to understand specific legal confirmations regarding the ATM Program.
- Confirm the status and remaining capacity of the ATM Program under the Sales Agreement dated September 5, 2025.
- Review the Company's most recent 10-K or 10-Q filings for actual financial performance data, as this 8-K contains no financial metrics.